Free Trial

Cronos Group (CRON) Competitors

Cronos Group logo
$2.50 -0.02 (-0.79%)
Closing price 10/21/2025 04:00 PM Eastern
Extended Trading
$2.48 -0.02 (-1.00%)
As of 10/21/2025 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

CRON vs. ACB, CGC, OGI, SNDL, TLRY, VKTX, LNTH, MIRM, ZLAB, and ADMA

Should you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurora Cannabis (ACB), Canopy Growth (CGC), Organigram Global (OGI), SNDL (SNDL), Tilray Brands (TLRY), Viking Therapeutics (VKTX), Lantheus (LNTH), Mirum Pharmaceuticals (MIRM), Zai Lab (ZLAB), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry.

Cronos Group vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends, risk and media sentiment.

Cronos Group has lower revenue, but higher earnings than Aurora Cannabis. Aurora Cannabis is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.17$1.63M-$0.19-27.05
Cronos Group$117.61M8.14$41.08M$0.0550.00

47.6% of Aurora Cannabis shares are held by institutional investors. Comparatively, 8.7% of Cronos Group shares are held by institutional investors. 0.0% of Aurora Cannabis shares are held by company insiders. Comparatively, 6.9% of Cronos Group shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Cronos Group has a net margin of 14.19% compared to Aurora Cannabis' net margin of -5.66%. Aurora Cannabis' return on equity of -1.49% beat Cronos Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
Cronos Group 14.19%-3.78%-3.62%

In the previous week, Aurora Cannabis had 1 more articles in the media than Cronos Group. MarketBeat recorded 1 mentions for Aurora Cannabis and 0 mentions for Cronos Group. Cronos Group's average media sentiment score of 1.00 beat Aurora Cannabis' score of 0.50 indicating that Cronos Group is being referred to more favorably in the news media.

Company Overall Sentiment
Aurora Cannabis Positive
Cronos Group Positive

Aurora Cannabis has a beta of 1.75, meaning that its stock price is 75% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
Cronos Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

Aurora Cannabis beats Cronos Group on 9 of the 16 factors compared between the two stocks.

Get Cronos Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRON vs. The Competition

MetricCronos GroupMED IndustryMedical SectorNASDAQ Exchange
Market Cap$964.89M$3.01B$6.22B$10.68B
Dividend YieldN/A57.76%5.72%4.88%
P/E Ratio50.0023.5929.1427.22
Price / Sales8.14759.15577.06128.38
Price / Cash5,415.63171.3937.5161.65
Price / Book0.865.4112.476.59
Net Income$41.08M$33.06M$3.32B$276.14M
7 Day Performance-3.10%-0.68%0.80%-0.72%
1 Month Performance-3.47%8.13%7.32%2.47%
1 Year Performance9.17%-2.15%63.84%33.90%

Cronos Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRON
Cronos Group
1.0654 of 5 stars
$2.50
-0.8%
N/A+17.4%$964.89M$117.61M50.00450Positive News
ACB
Aurora Cannabis
0.5417 of 5 stars
$5.40
+1.9%
N/A-6.7%$303.60M$357.88M-28.421,130
CGC
Canopy Growth
0.8949 of 5 stars
$1.37
flat
N/A-68.4%$328.59M$274.92M-0.453,150
OGI
Organigram Global
0.7391 of 5 stars
$1.92
+0.5%
N/A-2.3%$257.94M$223.82M38.41860News Coverage
SNDL
SNDL
3.0686 of 5 stars
$2.48
-1.6%
$4.50
+81.5%
+11.9%$651.68M$944.25M-9.182,516
TLRY
Tilray Brands
3.3295 of 5 stars
$1.69
-1.7%
$2.00
+18.3%
-6.3%$1.86B$210.48M-0.742,842
VKTX
Viking Therapeutics
3.999 of 5 stars
$33.91
+1.0%
$86.42
+154.8%
-48.7%$3.81BN/A-22.1620
LNTH
Lantheus
4.5923 of 5 stars
$54.59
+2.0%
$74.50
+36.5%
-48.5%$3.71B$1.53B14.52700Trending News
MIRM
Mirum Pharmaceuticals
4.1416 of 5 stars
$72.17
-0.7%
$76.50
+6.0%
+75.3%$3.63B$429.16M-59.64140
ZLAB
Zai Lab
2.6629 of 5 stars
$31.23
+3.3%
$56.35
+80.4%
+4.1%$3.49B$398.99M-15.311,869Gap Up
ADMA
ADMA Biologics
3.6857 of 5 stars
$14.55
+0.1%
$27.67
+90.1%
-5.8%$3.47B$426.45M16.92530

Related Companies and Tools


This page (NASDAQ:CRON) was last updated on 10/22/2025 by MarketBeat.com Staff
From Our Partners